Therapeutic Area Market Research Reports & Industry Analysis

The Therapeutic Area Market refers to a specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It is a way to classify drugs without reference to the type of therapy, form of action, or the company that makes it, but instead to look at the disease it treats.

Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.

Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.

...Show More ...Show Less


Therapeutic Area Industry Research & Market Reports

  • Asthma Therapeutics

    ... at a CAGR of 2.3% over the analysis period 2023-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$10.7 Billion by the end of ... Read More

  • Cervical Dystonia Market Insight, Epidemiology And Market Forecast - 2034

    ... professionals and the general public regarding cervical dystonia, alongside the aging population. The diagnosis of cervical dystonia relies on clinical examination, thorough patient history assessment, and a deep understanding of the disorder. No specific laboratory ... Read More

  • Amyotrophic Lateral Sclerosis

    ... by 2030, growing at a CAGR of 19.4% over the analysis period 2023-2030. The U.S. Market is Estimated at US$285.8 Million While China is Forecast to Grow at 18.4% CAGR The Amyotrophic Lateral Sclerosis market ... Read More

  • Dermatoscopes

    ... of 13.1% over the analysis period 2023-2030. Contact Dermatoscope, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More

  • Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024

    ... Macular Degeneration (Wet AMD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More

  • Orthotics (UK) - Industry Report

    ... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Orthotics (UK) report will tell you the companies that have a declining financial ... Read More

  • Renal Biomarkers

    ... at a CAGR of 6.5% over the analysis period 2023-2030. Functional Biomarkers, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.1 Billion by the end of ... Read More

  • Vaginal Odor Control Product

    ... reach US$5.7 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Intimate Wash, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach ... Read More

  • Atopic Dermatitis Drugs

    ... by 2030, growing at a CAGR of 21.1% over the analysis period 2023-2030. Biologics Drug Class, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$18.7 Billion ... Read More

  • Global Cytomegalovirus Infection Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032

    ... Segment Forecasts, 2023 – 2032 Global Cytomegalovirus Infection Market was valued at US $550.2 Million in 2022 and is expected to reach US $995 Million by 2032, growing at a CAGR of 6.1% during the ... Read More

  • Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030

    ... Others), End-User (Hospitals, Research Institutions & Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising ... Read More

  • Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034

    ... of Atherosclerotic Cardiovascular Disease in the 7MM is expected to increase, driven by better diagnosis and launch of emerging therapies. DelveInsight’s analyst projects that among the total cases of ASCVD in 7MM approximately 47% of ... Read More

  • Global Gastric Cancer Market (2024 Edition): Analysis By Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors), By Therapy, By Drug Class, By Region, By Country: Market Insights and Forecast (2020-2030)

    ... released a research report titled “Global Gastric Cancer Market (2024 Edition)” which provides a Gastric Cancer/Gastroesophageal Junction Cancer analysis of the Global Gastric Cancer industry in terms of market segmentation By Indication (Gastric Cancer/Gastroesophageal Junction ... Read More

  • Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034

    ... be further sub-divided into B cells, T cells and NK cells. Lymphomas are broadly divided into two major categories: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). When NHL begins in the skin (not in another ... Read More

  • Critical Care Therapeutics

    ... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Albumin Drug Class, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$3.7 Billion ... Read More

  • Pneumonia Therapeutics

    ... at a CAGR of 6.6% over the analysis period 2023-2030. Pneumonia Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of ... Read More

  • Kaposi Sarcoma

    ... at a CAGR of 3.1% over the analysis period 2023-2030. HAART, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$101.5 Million by the end of the ... Read More

  • Psychologists (UK) - Industry Report

    ... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Psychologists (UK) report will tell you the companies that have a declining financial ... Read More

  • Radiology Information Systems

    ... by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Integrated Radiology Information Systems, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 ... Read More

  • Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology And Market Forecast - 2034

    ... care that involves the prescription of riluzole has been effective in slowing the disease progression, thereby increasing the life span of patients. The most recent development in ALS was the addition of RELYVRIO for the ... Read More

  • Artificial Joints

    ... at a CAGR of 4.4% over the analysis period 2023-2030. Ceramics Material, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$17.3 Billion by the end of ... Read More

  • Rare Endocrine Disease Treatment

    ... reach US$14.4 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Acromegaly Treatment, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach ... Read More

  • Artificial Saliva

    ... at a CAGR of 13.5% over the analysis period 2023-2030. Oral Sprays, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach US$1.3 Billion by the end of ... Read More

  • Kidney Function Tests

    ... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Dipsticks, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$765.0 Million by the ... Read More

  • Global Pulmonary Drug Delivery Devices Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2030

    ... End-user, By Region, and Segment Forecasts, 2023 – 2030 Global Pulmonary drug delivery devices market was valued at US $35.6 Billion in 2022 and is expected to reach US $48.5 Billion by 2030, growing at ... Read More

Cookie Settings